135 results on '"Sheares, K."'
Search Results
2. Diagnosis of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) by Cardiologists and Pulmonologists - a Global Cross-Sectional Scientific Survey (CLARITY)
3. (976) Assessment of Clinical Practices and Unmet Needs in Chronic Thromboembolic Pulmonary Hypertension (CTEPH) - A Global Cross-Sectional Scientific Survey (CLARITY)
4. Chronic thromboembolic pulmonary hypertension global cross-sectional scientific survey (CLARITY) – interim results on the adoption and perception of guidelines
5. Age should not be a barrier to pulmonary endarterectomy in carefully selected patients: P184
6. Adamts13 protein levels are decreased in chronic thromboembolic pulmonary hypertension and implicated in its pathobiology: S109
7. Genome-wide association study in chronic thromboembolic pulmonary hypertension reveals new insights into aetiology: S108
8. Camphor score: sustained improvement in patient reported outcomes following pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension: S50
9. Patient pathway mapping of uk referrals to the national pulmonary endarterectomy mdt (june 2015 - may 2016): S51
10. Prevalence and clinical impact of atrioventricular conduction disease in patients with idiopathic pulmonary arterial hypertension
11. S71 Influence of age on clinical phenotypes of incident idiopathic pulmonary arterial hypertension. Results from the pulmonary hypertension registry of the UK and Ireland
12. S72 Prediction of survival in pulmonary arterial hypertension using survival equations. Results from the pulmonary hypertension registry of the UK and Ireland
13. S25 Incidence of surgically treated patients with chronic thromboembolic pulmonary hypertension in the UK during the last decade
14. S22 Improved symptoms and quality of life after pulmonary endarterectomy (PEA) in patients with chronic thromboembolic disease (CTED) and borderline pulmonary hypertension (PH)
15. Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom
16. An international survey of clinicians regarding their management of venous thromboembolism following the initial 3–6 months of anticoagulation
17. S97 Inflammatory cytokines are elevated in patients with operable chronic thromboembolic pulmonary hypertension and predict outcome post-endarterectomy
18. S100 Change in diastolic pulmonary artery pressure (3 months post surgery compared to pre-surgery value) as a long-term prognostic parameter in patients treated with pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension
19. S83 THE ROLE OF CYCLOOXYGENASE-2 AND ITS INTRACELLULAR SIGNALLING PATHWAYS IN THE HYPOXIC REGULATION OF GROWTH OF PERIPHERAL PULMONARY ARTERY SMOOTH MUSCLE CELLS
20. New insights into oxygen sensing at a cellular level
21. P119 Evolving surgical expertise and patient choice in pulmonary endarterectomy
22. P117 Machine learning tool provides new insights into risk assessment in pulmonary endarterectomy
23. P118 Defining a minimal clinically important difference in CAMPHOR
24. Minimal Clinically Important Distance Measured by Six-Minute Walking Distance in Patients with IPAH
25. A Multicentre Study of Anticoagulation in Operable Chronic Thromboembolic Pulmonary Hypertension
26. S51 Patient pathway mapping of uk referrals to the national pulmonary endarterectomy mdt (june 2015 – may 2016)
27. P184 Age should not be a barrier to pulmonary endarterectomy in carefully selected patients
28. S108 Genome-wide association study in chronic thromboembolic pulmonary hypertension reveals new insights into aetiology
29. S50 Camphor score: sustained improvement in patient reported outcomes following pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension
30. S109 Adamts13 protein levels are decreased in chronic thromboembolic pulmonary hypertension and implicated in its pathobiology
31. P29 Exercise intolerance in chronic thromboembolic disease: evaluation, underlying mechanisms and clinical implications
32. P27 Evaluation and baseline characteristics of patients with chronic thromboembolic disease in a single referral centre
33. P265 The clinical utility of biomarkers associated with inflammation and endothelial dysfunction in CTEPH: Abstract P265 Table 1
34. S122 Outcome After Pulmonary Endarterectomy (pea): Long Term Follow-up Of The Uk National Cohort
35. S37 Vascular Endothelial Cell Growth Factor-a (vegf-a) Signalling And Neovascularisation Of Pulmonary Endarterectomy Material In Chronic Thromboembolic Pulmonary Hypertension (cteph)
36. P16 A Systematic Characterisation Of Inflammation In Chronic Thromboembolic Pulmonary Hypertension
37. Occlusion pressure analysis role in partitioning of pulmonary vascular resistance in CTEPH.
38. Incapacity to increase cardiac output determines 6 minute walk distance in pulmonary hypertension
39. Clinical presentation of patients with chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension
40. Incapacity to increase cardiac output determines 6 minute walk distance in chronic thromboembolic pulmonary hypertension
41. S46 Outcome after pulmonary endarterectomy (PEA): Long term follow-up of the UK national cohort: Abstract S47 Table 1.
42. Pulmonary Endarterectomy in Patients with Borderline Pulmonary Hypertension
43. S39 Whole Exome Sequencing in Chronic Thromboembolic Pulmonary Hypertension Reveals Biologically Plausible Novel Genetic Variation
44. S41 Conductance-Derived Right Ventricular Stroke Work Measured by Pressure Volume Loops in Chronic Thromboembolic Pulmonary Vascular Disease
45. Pulmonary endarterectomy: outcomes in patients aged >70
46. Maximal Cardiac Output Determines 6 Minutes Walking Distance In Pulmonary Hypertension
47. P3 Are inflammatory cytokine levels altered by treatment of pulmonary arterial hypertension?
48. 219 Right Ventricular Reverse Remodeling after Pulmonary Endarterectomy: Assessment by Magnetic Resonance Imaging
49. Unexplained iron deficiency in idiopathic and heritable pulmonary arterial hypertension
50. Two Consecutive Measurements of N-Terminal Pro-Brain Natriuretic Peptide Allow Long-Term Prediction of Adverse Clinical Events.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.